Confirmed Plenary Speakers for the 2018 IBTN Conference


We are thrilled to announce the following confirmed speakers for the upcoming International Behavioral Trials Network Conference next May 24-26 in Montreal!

Full program details (including new speakers, plenary sessions, workshops, poster sessions, and networking activities) to follow! For further information, contact the IBTN team: team@ibtnetwork.org


 

 

Susan Michie, PhD (University College London)
Professor of Health Psychology at University College London (UCL) and Director of its Centre for Behaviour Change and of the Health Psychology Research Group. She leads the Human Behaviour-Change Project, holds an NIHR Senior Investigator’s award, is Associate Editor of Annals of Behavioral Medicine and Fellow of SBM, AcBehMedRes, AcMedSci, AcadSocSci, EHPS and BPS.
Robert Kaplan, PhD (Standford University)
Regenstrief Distinguished Fellow at Purdue University, Adjunct Professor of Medicine at Stanford University, and Director of Research at the Stanford School of Medicine Clinical Excellence Research Center (CERC). He also served as Chief Science Officer at the US Agency for Health Care Research and Quality (AHRQ) and Associate Director of the National Institutes of Health. He is also a Distinguished Emeritus Professor of Health Services and Medicine at UCLA, where he led the UCLA/RAND AHRQ health services training program and the UCLA/RAND CDC Prevention Research Center. He has served as co-chair of the Social Behavioral and Economics Sciences subcommittee (of Committee of Science) of the US National Science and Technology Council, within the United States Executive Office of the President.
Jeremy Grimshaw, MD, PhD (University of Ottawa)
Senior Scientist in the Clinical Epidemiology Program at the Ottawa Hospital Research Institute and Full Professor at the University of Ottawa’s Department of Medicine. He is also Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake, Co-Chair of the Steering Group for the Campbell Collaboration, a Fellow of the Canadian Academy of Health Sciences, a Corresponding Fellow of the Royal Society of Edinburgh and a Member of the Centre for Implementation Research.
 Linda Collins, PhD (Pennsylvania State University)
Director of Pennsylvania State University’s The Methodology Center, Distinguished Professor in the Department of Human Development and Family Studies and Professor in the Department of Statistics.
Robert West, PhD (University College London)
Professor of Health Psychology at University College London, and Director of Tobacco Studies for the Cancer Research UK Health Behaviour Unit in the Department of Epidemiology and Public Health at University College London.
Lynda Powell, PhD (Rush University)
Charles J. and Margaret Roberts Professor of Preventive Medicine, Medicine (Cardiology), Behavioral Sciences, and Pharmacology, and chairperson of the Department of Preventive Medicine at Rush University Medical Center in Chicago. She has been a past principal investigator of five major randomized behavioral trials and has served as a standing member of the NHLBI Clinical Trials Study Section. She is currently the principal investigator of the Chicago site of the NHLBI-sponsored Obesity-Related Behavioral Intervention Trials (ORBIT) network. She is a founding faculty member in the NIH/OBSSR-sponsored Summer Institute for Randomized Clinical Trials Involving Behavioral Interventions. She is currently in the process of writing the first book on the strategy of behavioral randomized clinical trial methodology.
Jean Bourbeau, MD (McGill University)
Respirologist and Professor in the Department of Medicine and Epidemiology & Biostatistics at McGill University, and director of the McConnell Centre of Innovative Medicine (CIM) of the Research Institute of the MUHC (RIMUHC) and the Pulmonary Rehabilitation Unit at the Montreal Chest Institute of the McGill University Health Centre (MUHC). He also chairs the COPD axis of the Health Respiratory Network of the FRQS (Fonds de recherche du Québec – Santé), past president and current member of the Canadian Thoracic Society, and sits on the scientific committee of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) and leading/co-leading Guidelines/Position statements in COPD (CTS, Chest, ATS/ERS, and GOLD).
Bonnie Spring, PhD (Northwestern University)
Professor of Preventive Medicine, Psychology, and Psychiatry at Northwestern University and Director of the Center for Behavior and Health of its Institute for Public Health and Medicine. She serves on the American Psychological Association’s Advisory Steering Committee to Develop Clinical Treatment Guidelines, chairs the American Heart Association’s Health Behavior Change Committee, and author of NIH-funded on-line learning modules on evidence-based practice (ebbp.org). She is also founding editor and editor-in-chief of Translational Behavioral Medicine: Practice, Policy, Research.
Ken Freedland, PhD (Washington University)
Professor of Psychiatry and Psychology at Washington University School of Medicine and co-investigator and clinical supervisor for the multicenter Enhancing Recovery in Coronary Heart Disease (ENRICHD), a co-investigator and assessment core leader for the multicenter CODIACS Vanguard trial, and a co-investigator and clinical supervisor for the multicenter INSPIRE trial of stress management for lung transplant candidates. He is also a founding fellow of the Academy of Cognitive Therapy (ACT) and an ACT-certified cognitive therapy trainer, an instructor in clinical trial methodology on the faculty of the National Institutes of Health Annual Summer Institute on Randomized Behavioural Clinical Trials.
Paul Montgomery, PhD (University of Birmingham, UK)
Professor of Social Intervention at the School of Social Policy at the University of Birmingham, and lead on the development of the CONSORT-SPI, a reporting guideline for randomised trials of complex psychological and social interventions. He maintains a clinical social work practice and specialises in Brief Intervention and Cognitive Behavioural techniques.
Linda Carlson, PhD (University of Calgary)
Enbridge Research Chair in Psychosocial Oncology, Alberta Innovates-Health Solutions Health Scholar, Full Professor in Psychosocial Oncology in the Department of Oncology, Cumming School of Medicine at the University of Calgary, and Adjunct Professor in the Department of Psychology. She is also the Director of Research and works as a Clinical Psychologist at the Department of Psychosocial Resources at the Tom Baker Cancer Centre, and is a fellow of the Society of Behavioral Medicine and the Mind and Life Institute.
David Buckeridge, PhD (McGill University)
Associate Professor of Epidemiology and Biostatistics at McGill University where he holds a Canadian Institutes of Health Research Chair in Applied Public Health. He is also a Medical Consultant to the Montreal Public Health Department and the Quebec Public Health Institute.
Molly Byrne, PhD (National University of Ireland, Galway)
Professor of Health Psychology at the National University of Ireland, Galway and recipient of the Health Research Board (HRB, Ireland) Research Leadership Award (2014-2019) to establish and direct the Health Behaviour Change Research Group (HBCRG).
Kim Lavoie, PhD (Université du Québec à Montréal)
Co-Director of the Montréal Behavioural Medicine Centre, co-lead of the International Behavioural Trials Network (IBTN) and former Director of the Chronic Disease Research Division at Hôpital du Sacré-Coeur de Montréal. She is a Full Professor in the Department of Psychology and Chair of Behavioral Medicine at the Université du Québec à Montréal. She is also Chair of Health Psychology and Behavioural Medicine at the Canadian Psychological Association and an active member of the CHEP recommendation panel (Adherence Subcommittee). She currently holds a Quebec Health Research (FRQS) Senior Investigator Award.
Grégory Ninot, PhD (University of Montpellier)
Professor at the University of Montpellier, France, Director of the CEPS Platform, dedicated to improving the methodology of behavioral trials, and co-lead of the International Behavioural Trials Network.
Susan Czajkowski, PhD (National Cancer Institute)
Chief of the Health Behaviors Research Branch (HBRB) of the National Cancer Institute (NCI) and previously project officer for the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients Study and lead project officer for the NIH-funded Obesity-Related Behavioral Intervention Trials (ORBIT) network. She is also a fellow in the Society of Behavioral Medicine, and recently served as President of the Academy of Behavioral Medicine Research.
Simon Bacon, PhD (Concordia University)
Professor in the Department fo Exercise Science at Concordia University, Canadian Institutes of Health Research (CIHR) Strategy for Patient-Oriented Research (SPOR) Chair in Innovative, Patient-Oriented, Behavioural Clinical Trials, Co-Director of the Montréal Behavioural Medicine Centre, fellow of the Obesity Society and the Canadian Cardiovascular Society, and researcher at the Centre intégré universitaire de santé et service sociaux du Nord-de-l’Île-de-Montréal  (CIUSSS-NIM) and co-lead of the International Behavioural Trials Network.